Sweeney, EileenDahly, DarrenSeddiq, NahedCorcoran, GerardHorgan, MarySadlier, Corinna2019-05-202019-05-202019-05-091471-23343107239610.1186/s12879-019-4026-zhttp://hdl.handle.net/10147/624709Tuberculosis (TB) is the ninth leading cause of death worldwide and the leading cause from a single infectious agent. Bacillus Calmette-Guerin (BCG) is the only licensed vaccine for TB, yet its efficacy remains debated with variations in vaccine sub-strains, policies, and practices observed across the world. Three BCG vaccination policies were implemented across adjoining regions in the South West of Ireland from 1972; neonatal vaccination (vaccinated Region-A), vaccination of children aged 10–12 years (vaccinated Region-B) and no vaccination (unvaccinated Region-C). The aim of this study is to examine the impact of different BCG vaccination policies on incidence of TB disease in the South of Ireland over a 13-year period.enAttribution-NonCommercial-NoDerivs 3.0 United Stateshttp://creativecommons.org/licenses/by-nc-nd/3.0/us/Bacille Camille-Guerin (BCG)Mycobacterium tuberculosis (MTB)VaccinesTUBERCULOSISIMMUNISATIONPUBLIC HEALTHImpact of BCG vaccination on incidence of tuberculosis disease in southern Ireland.ArticleBMC Infectious Diseases